Fredun Pharmaceuticals Ltd. BSE: 539730 |

Fredun Pharma Live Share Price Today, Share Analysis and Chart

Name: Fredun Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Fredun Pharmaceuticals Ltd.
Rating: 2.89075
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Fredun Pharmaceuticals is dedicated to improving lives of people. Company’s aim is not only profitability but is effective efficiency. With years of experience in manufacturing various pharmaceutical formulations Fredun Pharmaceuticals Ltd has built ...

1838.00 41.40 (2.30%)

189.43% Gain from 52W Low

BSE Volume

BSE 10 Feb, 2026 9:09 AM (IST)

Board Meeting

The latest board meeting for Fredun Pharma took place on 09 Feb 2026, for the purpose of Quarterly Results See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

69.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

No estimates available

Fredun Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Fredun Pharmaceuticals Ltd. worth buying?

37 Votes:

Buy 75.68%

Sell 16.22%

Hold 8.11%

Fredun Pharma Live Share Price Today, Share Analysis and Chart

Fredun Pharmaceuticals is dedicated to improving lives of people. Company’s aim is not only profitability but is effective efficiency. With years of experience in manufacturing various pharmaceutical formulations Fredun Pharmaceuticals Ltd has built ...

189.43% Gain from 52W Low

SWOT Analysis

Fredun Pharma Live Price Chart